Detalhe da pesquisa
1.
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
J Viral Hepat;
31(1): 21-34, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37936544
2.
Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
Clin Infect Dis;
77(1): 46-55, 2023 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36869823
3.
National trends in retreatment of HCV due to reinfection or treatment failure in Australia.
J Hepatol;
78(2): 260-270, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36152766
4.
Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C).
J Viral Hepat;
30(5): 386-396, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36651627
5.
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.
Clin Infect Dis;
75(10): 1809-1819, 2022 11 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35362522
6.
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
J Viral Hepat;
2022 May 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35583922
7.
Corrigendum to 'National trends in retreatment of HCV due to reinfection or treatment failure in Australia' (J Hepatol [2023] 260-270).
J Hepatol;
78(5): 1084, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36898934
8.
Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021.
Hepatol Commun;
7(4)2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36995991
9.
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis.
Lancet Reg Health West Pac;
36: 100750, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37547040
10.
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study.
J Int AIDS Soc;
26(9): e26168, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37675828
11.
Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case-Control Diagnostic Validation Study.
Pathogens;
12(10)2023 Oct 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37887764
12.
Reinfection incidence and risk among people treated for recent hepatitis C virus infection.
AIDS;
37(12): 1883-1890, 2023 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37467042
13.
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study.
Hepatol Commun;
6(3): 496-512, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34729957
14.
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort.
Health Sci Rep;
5(5): e719, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36000082
15.
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort.
Int J Drug Policy;
96: 103422, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34426040
16.
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
AIDS;
34(9): 1347-1358, 2020 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32590433